All In Biotech

Drug Trial Radar · NCT03668041

National Adaptive Trial for PTSD Related Insomnia

CSP #2016 - National Adaptive Trial for PTSD Related Insomnia

Last checked: Nov 19, 2026Latest source record: Jun 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 673 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

673

Actual

Start

Feb 25, 2021

Primary completion

Mar 30, 2026

Study completion Mar 30, 2026

Sponsor

Lead sponsor
VA Office of Research and DevelopmentFederal agency
Sponsor type
Federal agency
First posted
Sep 12, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Many Veterans with posttraumatic stress disorder (PTSD) have trouble sleeping or have frequent nightmares. So far, no medication has been approved for treatment of insomnia in PTSD. The purpose of this research study is to find out if taking medications called trazodone or eszopiclone can help decrease symptoms of insomnia in patients with PTSD. PTSD is a form of intense anxiety which sometimes results from severe trauma. Symptoms may include nightmares, flashbacks, troublesome memories, difficulty sleeping, poor concentration, irritability, anger, and emotional withdrawal. Insomnia is a disorder that can make it hard to fall sleep, stay asleep or cause a person to wake up too early and not be able to fall back to sleep.

Conditions

  • Insomnia

Interventions

  • TrazodoneDrug

    Trazodone is approved by the Food and Drug Administration (FDA) for treating major depression in adults but not for PTSD. Although trazodone has not been approved by the FDA to treat insomnia or PTSD, some doctors have tried it for these purposes. The doses in this study will be lower than the doses used to treat depression.

  • EszopicloneDrug

    Eszopiclone is approved by the FDA for treating insomnia, but it's unknown if eszopiclone can help treat insomnia when it's related to PTSD. Some doctors have tried it for this purpose. The doses in this study will be the same as the doses used to treat insomnia. A small study found it to be helpful for treating patients with PTSD.

  • PlaceboOther

    The active study medications listed above will be compared with a placebo, which is a pill that looks like a study medication but has no medication in it.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Insomnia Severity IndexTime frame: Baseline to 12 weeks

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • Birmingham VA Medical Center, Birmingham, AL

    Birmingham, Alabama

  • Tuscaloosa VA Medical Center, Tuscaloosa, AL

    Tuscaloosa, Alabama

  • Phoenix VA Health Care System, Phoenix, AZ

    Phoenix, Arizona

  • VA Loma Linda Healthcare System, Loma Linda, CA

    Loma Linda, California

  • VA Long Beach Healthcare System, Long Beach, CA

    Long Beach, California

  • VA Palo Alto Health Care System, Palo Alto, CA

    Palo Alto, California

  • VA San Diego Healthcare System, San Diego, CA

    San Diego, California

  • San Francisco VA Medical Center, San Francisco, CA

    San Francisco, California

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT

    West Haven, Connecticut

  • CERC (VISN1, West Haven, CT)

    West Haven, Connecticut

  • Bay Pines VA Healthcare System, Pay Pines, FL

    Bay Pines, Florida

  • Atlanta VA Medical and Rehab Center, Decatur, GA

    Decatur, Georgia

  • Edward Hines Jr. VA Hospital, Hines, IL

    Hines, Illinois

  • Overton Brooks VA Medical Center, Shreveport, LA

    Shreveport, Louisiana

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

    Boston, Massachusetts

  • Minneapolis VA Health Care System, Minneapolis, MN

    Minneapolis, Minnesota

  • New Mexico VA Health Care System, Albuquerque, NM

    Albuquerque, New Mexico

  • Asheville VA Medical Center, Asheville, NC

    Asheville, North Carolina

  • Durham VA Medical Center, Durham, NC

    Durham, North Carolina

  • Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC

    Salisbury, North Carolina

  • Cincinnati VA Medical Center, Cincinnati, OH

    Cincinnati, Ohio

  • Louis Stokes VA Medical Center, Cleveland, OH

    Cleveland, Ohio

  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    Philadelphia, Pennsylvania

  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

    Pittsburgh, Pennsylvania

  • Providence VA Medical Center, Providence, RI

    Providence, Rhode Island

  • Ralph H. Johnson VA Medical Center, Charleston, SC

    Charleston, South Carolina

  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

    Dallas, Texas

  • Michael E. DeBakey VA Medical Center, Houston, TX

    Houston, Texas

  • South Texas Health Care System, San Antonio, TX

    San Antonio, Texas

  • VA Salt Lake City Health Care System, Salt Lake City, UT

    Salt Lake City, Utah

  • White River Junction VA Medical Center, White River Junction, VT

    White River Junction, Vermont

  • Salem VA Medical Center, Salem, VA

    Salem, Virginia

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA

    Seattle, Washington

  • William S. Middleton Memorial Veterans Hospital, Madison, WI

    Madison, Wisconsin

  • Clement J. Zablocki VA Medical Center, Milwaukee, WI

    Milwaukee, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.